The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Alphagan 0.2% w/v (2 mg/ml) eye drops, solution

AbbVie LimitedPA1824/007/001

Main Information

Trade NameAlphagan 0.2% w/v (2 mg/ml) eye drops, solution
Active SubstancesBrimonidine tartrate
Dosage FormEye drops, solution
Licence HolderAbbVie Limited
Licence NumberPA1824/007/001

Group Information

ATC CodeS01EA Sympathomimetics in glaucoma therapy1)
S01EA05 brimonidine


License statusAuthorised
Licence Issued14/11/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back